Search Page

1

Cite

Share

Atypical metastatic pattern of prostate cancer detected with 68Ga-PSMA PET/CT.

Fech V, Sachpekidis C, Alberts I, Rominger A, Afshar-Oromieh A. Fech V, et al. Nuklearmedizin. 2020 Apr;59(2):85-86. doi: 10.1055/a-1108-1275. Epub 2020 Mar 18. Nuklearmedizin. 2020. PMID: 32189320 No abstract available.

Cite

Share

2

Cite

Share

The influence of colour scale in lesion detection and patient-based sensitivity in [68Ga]Ga-PSMA-PET/CT.

Mingels C, Sachpekidis C, Bohn KP, Hünermund JN, Schepers R, Fech V, Prenosil G, Rominger A, Afshar-Oromieh A, Alberts I. Mingels C, et al. Among authors: fech v. Nucl Med Commun. 2021 May 1;42(5):495-502. doi: 10.1097/MNM.0000000000001364. Nucl Med Commun. 2021. PMID: 33481506 Free article.

Cite

Share

3

Cite

Share

PSMA-negative prostate cancer and the continued value of choline-PET/CT.

Alberts I, Sachpekidis C, Fech V, Rominger A, Afshar-Oromieh A. Alberts I, et al. Among authors: fech v. Nuklearmedizin. 2020 Feb;59(1):33-34. doi: 10.1055/a-1044-1855. Epub 2019 Nov 25. Nuklearmedizin. 2020. PMID: 31766065 No abstract available.

Cite

Share

4

Cite

Share

Roles of CCR2 and CCR5 for Hepatic Macrophage Polarization in Mice With Liver Parenchymal Cell-Specific NEMO Deletion.

Bartneck M, Koppe C, Fech V, Warzecha KT, Kohlhepp M, Huss S, Weiskirchen R, Trautwein C, Luedde T, Tacke F. Bartneck M, et al. Among authors: fech v. Cell Mol Gastroenterol Hepatol. 2021;11(2):327-347. doi: 10.1016/j.jcmgh.2020.08.012. Epub 2020 Sep 4. Cell Mol Gastroenterol Hepatol. 2021. PMID: 32896623 Free PMC article.

Cite

Share

5

Cite

Share

The influence of digital PET/CT on diagnostic certainty and interrater reliability in [⁶⁸Ga]Ga-PSMA-11 PET/CT for recurrent prostate cancer.

Alberts I, Hünermund JN, Sachpekidis C, Mingels C, Fech V, Bohn KP, Rominger A, Afshar-Oromieh A. Alberts I, et al. Among authors: fech v. Eur Radiol. 2021 Oct;31(10):8030-8039. doi: 10.1007/s00330-021-07870-5. Epub 2021 Apr 15. Eur Radiol. 2021. PMID: 33856522 Free PMC article.

Cite

Share

6

Cite

Share

Elastin-based molecular MRI of liver fibrosis.

Ehling J, Bartneck M, Fech V, Butzbach B, Cesati R, Botnar R, Lammers T, Tacke F. Ehling J, et al. Among authors: fech v. Hepatology. 2013 Oct;58(4):1517-8. doi: 10.1002/hep.26326. Hepatology. 2013. PMID: 23424008 No abstract available.

Cite

Share

7

Cite

Share

⁶⁸Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer-a modified protocol compared with the common protocol.

Haupt F, Dijkstra L, Alberts I, Sachpekidis C, Fech V, Boxler S, Gross T, Holland-Letz T, Zacho HD, Haberkorn U, Rahbar K, Rominger A, Afshar-Oromieh A. Haupt F, et al. Among authors: fech v. Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):624-631. doi: 10.1007/s00259-019-04548-5. Epub 2019 Nov 1. Eur J Nucl Med Mol Imaging. 2020. PMID: 31673789

Cite

Share

8

Cite

Share

PSMA-ligand PET allows a more accurate therapeutic response evaluation of bone metastases in prostate cancer compared to computed tomography.

Fech V, Alberts I, Rominger A, Afshar-Oromieh A. Fech V, et al. Nuklearmedizin. 2019 May 13. doi: 10.1055/a-0895-5078. Online ahead of print. Nuklearmedizin. 2019. PMID: 31083752

Cite

Share

9

Cite

Share

Histidine-rich glycoprotein promotes macrophage activation and inflammation in chronic liver disease.

Bartneck M, Fech V, Ehling J, Govaere O, Warzecha KT, Hittatiya K, Vucur M, Gautheron J, Luedde T, Trautwein C, Lammers T, Roskams T, Jahnen-Dechent W, Tacke F. Bartneck M, et al. Among authors: fech v. Hepatology. 2016 Apr;63(4):1310-24. doi: 10.1002/hep.28418. Epub 2016 Feb 19. Hepatology. 2016. PMID: 26699087

Cite

Share

10

Cite

Share

CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.

Ehling J, Bartneck M, Wei X, Gremse F, Fech V, Möckel D, Baeck C, Hittatiya K, Eulberg D, Luedde T, Kiessling F, Trautwein C, Lammers T, Tacke F. Ehling J, et al. Among authors: fech v. Gut. 2014 Dec;63(12):1960-1971. doi: 10.1136/gutjnl-2013-306294. Epub 2014 Feb 21. Gut. 2014. PMID: 24561613 Free PMC article.

Cite

Share